Here's what traders are watching as we get closer to the first presidential debate on Monday.
Carol Pepper, CEO of Pepper International, shares her take on the market rally following yesterday's FOMC meeting.
Investors cheered no rate hike from the Fed, but there's more than meets the eye to today's rally.
After the Fed leaves rates unchanged, traders wonder what's really keeping rates on hold.
After many false starts, we're finally starting to see the IPO market gain ground in September.
UNITED NATIONS— President Barack Obama called on wealthier nations Tuesday to do more to help millions of refugees find new homes and asked all leaders to imagine what it would be like "if the unspeakable happened to us." Obama commented as the White House announced that more than four dozen U.S. businesses have pledged $650 million to help refugees.
Isle of Capri Casinos Inc., up $5.11 to $22.04. The casino and racetrack company agreed to be bought by Eldorado Resorts for $23 a share, or $950 million. Sarepta Therapeutics Inc., up $20.79 to $48.94.
NEW YORK— U.S. stocks wobbled and finished mostly lower Monday as investors waited for central bank meetings in the United States and Japan. Investors were indecisive as leaders of the Federal Reserve and Bank of Japan prepared to meet, and stocks swung several times between gains and losses. Russ Koesterich, head of asset allocation with BlackRock's Global...
So far, only one biosimilar is available in the U.S., a Novartis drug called Zarxio that's a copy of Amgen's Neupogen, for preventing infections in people getting chemotherapy or radiation treatment. By comparison, more than 20 biosimilar versions of seven biologic drugs are available in Europe. Late last month, FDA approved Novartis's Erelzi, a near-copy of...
NEW YORK— Johnson& Johnson said Friday that it is paying more than $4.3 billion in cash to buy the eye health unit of Abbott Laboratories as it seeks to boost its vision business. Johnson& Johnson said that the purchase will enter it into the cataracts surgery market and grow its own vision business, which includes Acuvue contact lenses. Shares of Johnson& Johnson...
The company said the deal is expected to close in the first quarter of 2017.
Johnson & Johnson will acquire Abbott Laboratories' eye-surgery equipment unit for $4.3 billion in cash. CNBC's Seema Mody reports.
We may have had a data deluge today, but right now this rally is all about Apple.
Apple's rally is about more than just Samsung's battery woes. There may be more to the iPhone 7 than meets the eye.
Stocks have gone on a roller coaster ride from Friday through today alone.
After turning down Mylan's $26B offer, shares of Perrigo have lost almost half their value.
Boston Fed President Eric Rosengren has reminded everyone the markets are not positioned for a September rate hike.
Reflecting on 9/11, the ripple effects and signs of new life downtown 15 years later.
Honest, the diaper & personal care company co-founded by Jessica Alba, has been in talks to sell the company, Recode reports.
With markets hovering at new highs, here's why traders are growing desperate.